Spinogenix is using small molecule drugs to regenerate synapses in patients with ALS, Alzheimer's disease, schizophrenia, ...

Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to ...

Glutamatergic synapses in particular can be viewed as one of the most complex subcellular specializations in the entire body.” To grapple with these complexities, the company is developing first ...

A wealth of data from histological, imaging, genetic and other studies implicate a loss of glutamatergic synapses in frontal cortex and other regions as a primary feature of schizophrenia ...

Richard Lounsbery Award recipient, will present the 2024 Lounsbery Lecture on "Neuron-glial Interactions in Health and ...

Our research supports that GluA4 subunit confers a minimal mechanism for activity-dependent AMPA-receptor regulation to facilitate plasticity during early development of glutamatergic synapses.

By studying the synapses through which pyramidal neurons in the brain's sensory cortex communicate, they have learned how the ...

As part of the announcements at RazerCon 2024, it has been revealed that a brand new version of Razer Synapse is available to download, and if you’re actively using any Razer peripherals ...